Co-Diagnostics, Inc. (CODX) is a Medical - Devices company in the Healthcare sector, currently trading at $1.38. It has a SharesGrow Score of 45/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is CODX = $6 (+334.8% upside).
Valuation: CODX trades at a trailing Price-to-Earnings (P/E) of -0 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.03.
Financials: revenue is $622,489, -68.9%/yr average growth. Net income is $47M (loss), growing at -59.8%/yr. Net profit margin is -7533.6% (negative). Gross margin is 64.3% (-19.7 pp trend).
Balance sheet: total debt is $1M against $21M equity (Debt-to-Equity (D/E) ratio 0.06, conservative). Current ratio is 3.87 (strong liquidity). Debt-to-assets is 5%. Total assets: $25M.
Analyst outlook: 2 / 5 analysts rate CODX as buy (40%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 35/100 (Fail), Future 52/100 (Partial), Income 10/100 (Fail).
